BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6769349)

  • 1. [Vitamin A in the overall therapy of uterine myoma].
    Palladi GA; Shtemberg MI; Tkachenko VT
    Akush Ginekol (Mosk); 1980 Jan; (1):13-5. PubMed ID: 6769349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gonadotropic function of the hypophysis in uterine myoma].
    Talina IS; Sokolova ZP; Fanchenko ND
    Akush Ginekol (Mosk); 1978 Jun; (6):10-5. PubMed ID: 677395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urgent problems of clinical practice in the conservative management of uterine myoma].
    Vikhliaeva EM
    Akush Ginekol (Mosk); 1980 Jan; (1):8-13. PubMed ID: 7377490
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
    Nakamura Y; Yoshimura Y; Yamada H; Maruyama K; Nanno T; Ubukata Y; Ando M; Takahashi K; Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1620-6. PubMed ID: 2126024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypophyseal gonadotropic function in uterine myoma patients with various ovarian secretory activities].
    Trubnikova LI
    Akush Ginekol (Mosk); 1981 Apr; (4):5-9. PubMed ID: 6787942
    [No Abstract]   [Full Text] [Related]  

  • 6. Gossypol in the treatment of endometriosis and uterine myoma.
    Han ML; Wang YF; Tang MY; Ge QS; Zhou LF; Zhu PD; Sun YT
    Contrib Gynecol Obstet; 1987; 16():268-70. PubMed ID: 3121251
    [No Abstract]   [Full Text] [Related]  

  • 7. Uterine leiomyoma: treatment with LHRH agonist.
    Maheux R; Lemay A
    Prog Clin Biol Res; 1986; 225():297-311. PubMed ID: 3097669
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific features of hormonal balance in patients with myoma of the uterus].
    Arakeliants AB; Bakuleva LP
    Sov Med; 1978 Aug; (8):140-4. PubMed ID: 705445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver function indices during the treatment of patients with uterine myoma using synthetic progestins].
    Palladi GA; Brezhneva NV
    Akush Ginekol (Mosk); 1988 Mar; (3):60-3. PubMed ID: 3400831
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of the volemic shifts during the use of norethisterone in the process of the dispensary management of uterine myoma].
    Landekhovskiĭ IuD; Zaĭdieva IaZ
    Akush Ginekol (Mosk); 1980 Jan; (1):18-20. PubMed ID: 7377468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structural and functional characteristics of the endometrium in uterine myoma at the early stages in detection of the tumor and during norsteroid treatment].
    Iakubovich DV; Kondrikov NI
    Akush Ginekol (Mosk); 1980 Jan; (1):41-2. PubMed ID: 7377477
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant therapy in uterine myoma].
    Vikhliaeva EM
    Vestn Ross Akad Med Nauk; 1997; (2):16-20. PubMed ID: 9376721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of 17-ketosteroids in the urine of patients with uterine myoma (Preliminary report)].
    Laudańska E; Lachowiczowa L; Nowopolska M
    Endokrynol Pol; 1966; 17(1):25-8. PubMed ID: 5944307
    [No Abstract]   [Full Text] [Related]  

  • 14. Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
    Rolland R; Franssen AM; Willemsen WN; Corbey RS
    Prog Clin Biol Res; 1986; 225():313-20. PubMed ID: 3097670
    [No Abstract]   [Full Text] [Related]  

  • 15. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
    Hilário SG; Bozzini N; Borsari R; Baracat EC
    Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical usefulness of GnRH agonist therapy for premenopausal women with uterine leiomyoma].
    Kurose T; Hando T; Shiota A
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):35-41. PubMed ID: 7844451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin A in gynecology].
    Herschberg AD; Canu M
    Gynecol Prat; 1970; 21(1):53-67. PubMed ID: 5447212
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
    Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
    Sokolova ZP
    Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.